1. Home
  2. IRON vs INSP Comparison

IRON vs INSP Comparison

Compare IRON & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$80.40

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$94.81

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
INSP
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
IRON
INSP
Price
$80.40
$94.81
Analyst Decision
Strong Buy
Buy
Analyst Count
13
17
Target Price
$108.85
$137.63
AVG Volume (30 Days)
646.9K
1.9M
Earning Date
11-06-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.77
EPS
N/A
1.48
Revenue
N/A
$882,622,000.00
Revenue This Year
N/A
$15.00
Revenue Next Year
N/A
$11.24
P/E Ratio
N/A
$64.67
Revenue Growth
N/A
16.81
52 Week Low
$30.82
$70.77
52 Week High
$99.50
$216.01

Technical Indicators

Market Signals
Indicator
IRON
INSP
Relative Strength Index (RSI) 35.05 38.00
Support Level $71.41 $93.05
Resistance Level $92.00 $97.10
Average True Range (ATR) 4.40 7.05
MACD -1.73 -5.53
Stochastic Oscillator 31.96 9.20

Price Performance

Historical Comparison
IRON
INSP

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: